EA-230, NaCl 29 mg/ml in water for injection clinical trials

An International, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Trial on the Effects of EA-230 on the Length of Hospital Stay Following On-Pump Coronary Artery Bypass Grafting Surgery

This study is testing a new medicine, EA-230, to see if it helps people recover faster after heart bypass surgery. Doctors want to know if it can shorten the time people need to stay in hospital after their operation.